US Stock MarketDetailed Quotes

ELV Elevance Health

Watchlist

504.720
-16.210-3.11%

Close Jul 18 16:00 ET

117.04BMarket Cap17.67P/E (TTM)

Elevance Health Stock Forum

BullnBearTrading

Jul 15 03:30

Earnings shift into high gear

A flood of earnings will be coming over the next three weeks. This week will feature mostly financial companies.
Monday: Goldman Sachs ( $Goldman Sachs(GS.US)$ ) and money manager Blackrock ( $Blackrock(BLK.US)$ )
Tuesday: Health-insurer UnitedHealth Group ( $UnitedHealth(UNH.US)$ ) , Bank of America ( $Bank of America(BAC.US)$ ) , Morgan Stanley ( $Morgan Stanley(MS.US)$ ) and Charles Schwab ( $Charles Schwab(SCHW.US)$ ) .
Wednesday: Chip-equipment maker ASML ( $ASML Holding(ASML.US)$ ) , pharm...

Moomoo Recap US

Apr 2 15:24

ColumnsMarket Pull Back? Finally? | Wall Street Today

RECAP
April rain better mean the stock market stops the pain by May: the market declined Tuesday, punctuated by the fall of fan favorite Tesla. The EV maker made less EV's than last year and dropped nearly 5%.
Stocks closed lower, the $S&P 500 Index(.SPX.US)$ was recently down about 0.72%. $NASDAQ 100 Index(.NDX.US)$ fell about 0.94%. $Dow Jones Industrial Average(.DJI.US)$ fell 1%.
MACRO
Job openings recorded by JOLTS were just shy of expectations...

Moomoo AI

Mar 14 05:33

High insider ownership aligns management incentives with shareholders, but recent insider share sales, especially below current price, are concerning. Lack of insider purchases over the last year adds to the unease.

Have Elevance Health Insiders Been Selling Stock?

Moomoo AI

Feb 21 06:04

Market optimism grows for the stock after years of progress. Despite slowing share price gains, the business may continue to execute with prowess.

Elevance Health's (NYSE:ELV) Investors Will Be Pleased With Their Favorable 72% Return Over the Last Three Years

Moomoo AI

Feb 3 08:08

Elevance Health's performance is commendable, particularly its high rate of return and significant reinvestment into its business, which has led to impressive earnings growth. Analysts expect the company's earnings to gain momentum in the future.

Elevance Health, Inc.'s (NYSE:ELV) Stock Is Going Strong: Is the Market Following Fundamentals?

Moomoo AI

Jan 24 08:45

Elevance's 2024 earnings guidance and cost control in its Medicare business may reassure investors. CEO Gail Boudreaux expects improved earnings in the Medicare business in 2024.

Elevance Offers Reassurance to Investors With Earnings, 2024 Guidance -- WSJ

Moomoo AI

Jan 24 06:20

Despite a decline in membership base, Elevance's financial performance and future guidance indicate a positive outlook. The company's ability to raise its dividend and report significant YoY growth in operating revenue, despite industry challenges, suggests strong financial management and resilience.

Elevance Health Sets 2024 Outlook Ahead of Consensus; Raises Dividend

股勇者

Jan 18 06:18

$UnitedHealth(UNH.US)$ why big dip? $Elevance Health(ELV.US)$

Moomoo Recap US

Jan 12 15:19

ColumnsWall Street Today | Stocks Almost Flat as JPMorgan's Dimon Warns of Stickier Inflation

RECAP
Investors Weigh Risks
US stocks once again closed little changed Friday as investors weighed positive inflation signs from the latest producer price index against the warnings gleaned from banks and other companies which were among the first to report fourth-quarter earnings.
The $S&P 500 Index(.SPX.US)$ closed less than 0.1% higher, while the $Nasdaq Composite Index(.IXIC.US)$ ended almost flat for the ...

Luzi Ann Santos

Jan 12 09:14

ColumnsUnitedHealth's Higher Medical Care Costs Send Jitters Across Health Insurers

$UnitedHealth(UNH.US)$ reported a higher-than-expected spending on patients' healthcare services in the fourth quarter, sending its stock and that of its peers lower.
UnitedHealth said the company's medical care ratio, which measures medical expenses paid as a percentage of insurance premiums, reached 85% in the fourth quarter. That's higher than the 84.1% expected by analysts surveyed by FactSet, according to a Dow Jon...

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall